Today’s blog post is the third, and last, blog post in a series focusing on trade secret law issues and trends. As announced, we will address practical questions and offer insights into how Belgian courts interpret and apply various aspects of the Belgian Trade Secrets Act[1], particularly as it relates to unlawful use, available remedies, and the burden of proof for trade secret misappropriation.Continue Reading Blog 3: Unlocking Trade Secret Protection in Belgium: Key Trends in Trade Secret Protection Before Belgian Courts

Located in the heart of Europe, Belgium is a true hub of logistics and innovation. It is for example home to one of Europe’s largest sea ports (with all the warehousing infrastructure that one would expect). Belgium also hosts several, globally leading biotech and life sciences clusters. It is no coincidence for example that pharma giant Pfizer has one of its largest production and packaging sites in Puurs, a small Belgian town, where it produces its Covid-19 vaccine. A few miles north, Jansen Pharmaceuticals has its HQ.
We are looking back on our series where we spotlight international issues in trade secret law under the Belgian Trade Secrets Act.
In our prior
In our prior
Today’s blog is the third in a series where we spotlight international issues in trade secret law, in particular, answering practical questions and providing insights into the application and interpretation by Belgian courts of specific aspects of the Belgian Trade Secrets Act. (See our first post
Today’s blog post is the second in a series where we spotlight international issues in trade secret law, in particular, answering practical questions and providing insights into the application and interpretation by Belgian courts of specific aspects of the Belgian Trade Secrets Act.